The latest news from Verily
Back to all posts
Better data, better care
Friday, January 10, 2020
Our mission at Verily is to make the world’s health data useful so that people enjoy healthier lives. We believe that by finding new ways to collect, organize and activate data, we can have a meaningful impact on patients, clinicians and healthcare broadly. Yet, we can only deliver the best care if we have the best evidence. The best evidence is generated by devices, digital tools, and molecular assays that create new data sets or bridge gaps in data collection to provide a more complete picture of health.
From the early days at Verily, we developed next generation sensors and tools that improve data collection for research and care - tools like the Verily Study Watch and the miniature continuous glucose meter we have developed with Dexcom. In parallel, we have been working on scientific collaborations, such as one focused on deeply understanding the immune system, to better characterize the spectrum from health to disease. We also created solutions that leverage machine learning to enhance clinical decision making and performance, with efforts like Verb Surgical and our Virtual Stainer program.
Unobtrusive bio-sensing through devices like Study Watch is an important new approach to understanding what happens in the body at any given moment in time, and can provide insights into how our bodies stay healthy or change and adapt with disease.
In order to truly impact evidence generation, we needed to develop the data infrastructure and tools that could organize and make sense of new and dynamic data streams in the context of more traditional healthcare data. This was the genesis of
Project Baseline
, our effort to contribute to a map of human health. The first step towards this broader mission is the
Project Baseline Health Study
, which aims to accelerate precision health and medicine by integrating state of the art testing, longitudinal monitoring and participant engagement. We have also been building the Baseline Platform to continue to optimize evidence generation through: more participant and clinician participation, faster execution, and better data.
Verily’s innovation in hardware, software and data infrastructure come together today in products and solutions that empower patients to take ownership of their health and help physicians and caregivers deliver more personalized and evidence-based care. For example, our virtual care clinic, Onduo, puts information in the hands of patients and providers. And we are working with hospitals and health systems to develop tools for identifying and supporting patients at highest risk of complications from disease.
Onduo is a virtual care program that includes tools, coaching and clinical support.
We are fortunate to work with individuals who are excellent in their domain. They are expert in their fields but also humble enough to know that we have to bring others together to bridge clinical research and clinical care. This is why partnership is fundamental to our work at Verily. We’ve accelerated our efforts thanks to Project Baseline study participants, the
American Heart Association
,
hospital consortia
, and
industry partners
who have been instrumental in our quest to democratize access to clinical research. Health system partners like
Atrius Health and VA Palo Alto
are deploying tools that solve specific population health and system efficiency challenges, enabling us to learn from clinicians on the front lines of care delivery.
Together, our teams and partners are improving outcomes for patients today while building the foundation needed for better health tomorrow.
Posted by Vivian Lee, President, Verily Health Platforms and Jessica Mega, Chief Medical and Scientific Officer at Verily
previous
